Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Abasaglar

Europe set to approve first Glivec generic

CHMP backs Teva version of Novartis' blockbuster cancer drug

- PMLiVE

Novo wins CHMP backing for Tresiba and diabetes first

EMA advisors recommend approval of once-daily at unique higher strength

- PMLiVE

FDA panel backs Sanofi’s Kynamro for high cholesterol

Recommendation comes despite safety concerns

Study shows Sanofi’s Zaltrap effective in colorectal cancer

Reinforces prospects following US approval

- PMLiVE

Sanofi acquires Colombian pharma manufacturing firm Genfar

Expands its Latin American generics portfolio

- PMLiVE

Sanofi promotes diabetes expert Paul Chew to chief medical officer

Takes over from Jean-Pierre Lehner who retires

- PMLiVE

Board member Engelbert Tjeenk Willink to leave Boehringer

Replaced by head of established markets Allan Hillgrove

Board member Engelbert Tjeenk Willink to leave Boehringer

Replaced by head of established markets Allan Hillgrove

- PMLiVE

Sanofi plans 900 job cuts in France in upheaval of research

Future of Toulouse site remains in balance

- PMLiVE

Sanofi signs tuberculosis research deal with TB Alliance

Aims to shorten regimens and tackle drug-resistant forms of infection

- PMLiVE

Boehringer cancer R&D programme bears first fruit

Submits afatinib in Europe to treat lung cancer

- PMLiVE

J&J to launch ‘innovation centres’ in US, UK and China

Will target local life sciences partnerships in early-stage innovation

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links